21oilM

Saudis cut supply on weakening demand outlook

Commodities 5 minutes to read

Summary:  Following a bumpy start to 2021 crude oil jumped higher after Saudi Arabia, increasingly viewed as the guardian of oil markets, unilaterally decided to cut production in February and March. While the price from a producer perspective received a welcome boost, the reasons behind the decision is probably driven by a growing concern about the near term outlook for demand. A renewed surge in corona virus cases, now also in Asia, has once again left the prevailing outlook challenged and with this in mind the cut not only looked well timed but also needed in order to prevent another setback


What is our trading focus?

OILUKMAR21 – Brent Crude Oil (March)
OILUSFEB21 – WTI Crude Oil (February)

____________________________________________________________________________________________________

Three days into the new year and the crude oil market has already seen its fair share of drama. After racing out of the gates on Monday to hit a fresh ten-month high on continued vaccine-optimism, it made a sudden about turn in response to what increasingly looks like a grim period ahead. Extended lockdowns and with that reduced mobility across the world is the current response to the fast mutating virus variant first seen in UK.

Into this uncertain outlook OPEC+ met in order to determine whether the market needed additional barrels on top of the 500,000 barrels/day agreed for January. A stubborn stance from Russia, who was looking for another increase, spooked the market and WTI and Brent both sold off before yesterday’s surprise outcome.

In the end, the group agreed on the most sensible outcome, i.e. to rollover current production levels to March. Topping up the agreement was the surprise unilateral production cut announced by Saudi Arabia, which increasingly is being seen as the guardian of the oil market. Setting worries aside the risk of yielding market share to others, especially US shale oil producers, the Saudis most likely concluded that the next few months could see weakness in Western world fuel demand spread to Asia where infections are rising quickly.

Following the initial price jump we believe the market will conclude that at best this decision would help stabilize the price of oil and not sending it higher at this stage. On that basis we maintain the view that while crude oil prices will eventually move higher, this is not the time, given the elevated level of uncertainty with regards to demand.

Crude oil has rallied hard since the early November vaccine news and while the weaker dollar and increased demand for reflation hedges have played its part, the ultimate driver for further price gains will be a pickup in global fuel demand. Something that we are unlikely to see until the vaccine rollout reach a level of penetration that can support renewed mobility and travel activity.

Following the US election win for Biden in November and the prospect for the democrats winning a paper thin senate majority, the focus on reflation hedges have supported a general appetite for commodities. At the end of 2020, speculators held a record 2.5 million lots long across 25 major commodity futures, representing a nominal value of $125 billion. While the two previous peaks in 2017 and 2018 were primarily led by the crude oil market, the chart below shows how bullish bets have been spread out more evenly between the three major sectors of energy, metals and agriculture.

While the biggest of these bets are held in crude oil with the combined 614k lots long in WTI and Brent representing a nominal value of $30 billion, it is worth keeping in mind that the net long remains well below the 1.1 million lots record from March 2018.

Buyers may attempt to drive Brent crude oil towards $55/b, the bottom of the 2019 consolidation range, but with the clouded demand outlook is unlikely to push it higher than that with support currently at $49/b followed by $46.60/b

06olh_oil1
Source: Saxo Group

Later today at 15:30 GMT, the US Energy Information Administration will release its “Weekly Petroleum Status Report”. The American Petroleum Institute reported late Tuesday that US crude oil stocks fell by 1.7 million barrels in the week to January 1. The data also showed a major gain in product stocks with gasoline and distillates rising a combined 12.6 million barrels. While the market impact given the period covered is likely to be limited, some focus will still be on implied demand for products in order to gauge the virus impact on consumers.

As per usual I will post the result on my Twitter handle @ole_s_hansen

06olh_oil2

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.